Evidence map›Paper›PMID 38787269›Full record

ReviewPathogens (Basel, Switzerland)2024

Human Cytomegalovirus Infection and Neurocognitive and Neuropsychiatric Health.

Shawn D Gale, Thomas J Farrer, Reagan Erbstoesser, Scott MacLean, Dawson W Hedges

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Cognition and Long COVID: a Review.Current neurology and neuroscience reports · 2026
    Review
  6. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shawn D GaleThe Department of Psychology, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0002-8989-0964
Thomas J FarrerIdaho WWAMI Medical Education Program, University of Idaho, Moscow, ID 83844, USA.ORCID 0000-0001-8092-6214
Reagan ErbstoesserThe Department of Biology, Brigham Young University, Provo, UT 84602, USA.
Scott MacLeanThe Department of Psychology, Brigham Young University, Provo, UT 84602, USA.
Dawson W HedgesThe Department of Psychology, Brigham Young University, Provo, UT 84602, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A common infection, human cytomegalovirus (HCMV) has been associated with a variety of human diseases, including cardiovascular disease and possibly certain cancers. HCMV has also been associated with cognitive, psychiatric, and neurological conditions. Children with congenital or early-life HCMV are at risk for microcephaly, cerebral palsy, and sensorineural hearing loss, although in many cases sensorineural loss may resolve. In addition, HCMV can be associated with neurodevelopmental impairment, which may improve with time. In young, middle-aged, and older adults, HCMV has been adversely associated with cognitive function in some but not in all studies. Research has linked HCMV to Alzheimer's and vascular dementia, but again not all findings consistently support these associations. In addition, HCMV has been associated with depressive disorder, bipolar disorder, anxiety, and autism-spectrum disorder, although the available findings are likewise inconsistent. Given associations between HCMV and a variety of neurocognitive and neuropsychiatric disorders, additional research investigating reasons for the considerable inconsistencies in the currently available findings is needed. Additional meta-analyses and more longitudinal studies are needed as well. Research into the effects of antiviral medication on cognitive and neurological outcomes and continued efforts in vaccine development have potential to lower the neurocognitive, neuropsychiatric, and neurological burden of HCMV infection.

Indexed as

CytomegalovirusCytomegalovirus InfectionsCognitionHumansMental Disorderscongenital CMVdementiahuman cytomegalovirus (HCMV)memoryneurocognitiveneuropsychiatric

Identifiers

PMID38787269
PMCPMC11123947

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.